FUJIFILM Diosynth Biotechnologies confirms £400 million investment plans to create the largest multi-modal biopharmaceutical manufacturing site in the United Kingdom The expansion is expected to create up to 350 highly-skilled jobs on Teesside.
December 2, 2021
Print
The expansion is expected to create up to 350 highly-skilled jobs on Teesside. BILLINGHAM, UK, 2 December 2021 FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organisation (CDMO) for biologics, viral vaccines and viral vectors, has confirmed a £400 million planned investment package at its UK facility in Billingham, Teesside. This investment package more than doubles the site's existing development and manufacturing footprint, creating the largest multi-modal biopharmaceutical manufacturing site in the United Kingdom1 and is expected to create up to 350 highly-skilled jobs. The new facilities are expected to be operational by late 2023.
The new multi-modal campus will include two new state-of-the-art facilities (a viral gene therapy GMP2 facility and a GMP mammalian cell culture facility) and is part of a 90 Billion Yen global capital investment package initially outlined by FUJIFILM Corporation in June
2021.
We all know that there has never been a more important time to invest in biopharmaceuticals - and £400 million, the largest investment in British biopharmaceutical manufacturing for decades, signals FUJIFILM Diosynth Biotechnologies' intent to be able to offer multi-modal options to respond to our customers' needs with flexibility and agility to help solve public health demands, and deliver the medicines and vaccines of tomorrow, said Martin Meeson, Chief Executive Officer of FUJIFILM Diosynth Biotechnologies. With a strong growing demand for microbial, cell culture and viral gene therapy services, we are adding the capacity and latest technologies within one campus to offer a range of modalities to build an offering that will deliver novel promising treatments to patients for years to come.
I am delighted that Fujifilm has identified the massive potential in the UK for growth and innovation. At £400m, this is a significant investment in British biopharmaceutical manufacturing and will power our response to some of today's most urgent global health challenges and deliver life-changing medicines and vaccines to patients in need said UK Prime Minister, Boris Johnson. It will enable the expansion of the Billingham campus and create 350 new jobs - attracting the best innovators and researchers and bolstering our Life Sciences industry as we build back better from the pandemic.
It's our vision for the FUJIFILM Diosynth Biotechnologies' site in Billingham to be the beating heart of the rapidly expanding North East Life Sciences ecosystem, and this investment will create up to 350 highly-skilled jobs and additional benefits across the local and national supply chain, added Paul Found, Chief Operating Officer, FUJIFILM Diosynth Biotechnologies UK.
The investment will add a new cell culture facility in the expanded Billingham campus and triple existing cell culture capacity capabilities at the site with the addition of 4x2,000L and 2x500L single use bioreactor production capabilities for the manufacture of both monoclonal and novel antibody treatments. This expansion will also include the addition of the company's MaruX GMP continuous manufacturing platform to provide customers with a differentiated connected and integrated production platform offering.
In addition to the cell culture facility, the new investment package will expand the viral vector and gene therapy services offered by FUJIFILM Diosynth Biotechnologies from the UK with dedicated process development capabilities and a commercial-scale viral gene therapy GMP facility, both located on the Billingham campus. This expansion will deliver a ten-fold increase in gene therapy production capabilities by FUJIFILM Diosynth Biotechnologies in the UK, cementing its leadership in the viral vector market; and complementing its existing global footprint including sites in College Station, Texas and Watertown, Massachusetts, both in the USA. The investment will also facilitate the expansion of existing capabilities in vaccine manufacturing, along with new capabilities including mRNA production.
FUJIFILM Diosynth Biotechnologies previously announced plans to expands its viral vector and gene therapy offerings in Darlington, UK, with process development laboratories and manufacturing capabilities to support the production of investigational use of gene therapies in early-stage clinical trials (first-in-human). The process development laboratories have already begun operations, with GMP manufacturing services starting in spring 2022.
Further to this, an expansion of the existing 5,000L GMP microbial production facilities will also take place at the Billingham campus. This expansion will increase microbial fermentation capacity by almost two-thirds. The expansion will include over 20,000 sq. ft of modular downstream clean room space, including two primary recovery and refolding suites, two purification suites and a column packing room. It is designed to implement FUJIFILM Diosynth Biotechnologies' SymphonX 3 technology. The expansion also includes quality control (QC) labs, office space and materials storage. This expansion will be operational by late 2023/early 2024.
1 Based on internal company research as of December 2021.
2 Good manufacturing practice
Media contact:
Andy Ross
Deputy Head of Corporate Communications - Europe
FUJIFILM Europe GmbH
Tel: +44(0)7766497949
Images FUJIFILM Diosynth Biotechnologies, Billingham, Teesside
FDB 1 [JPG]
FDB 2 [JPG]
FUJIFILM Diosynth Biotechnologies, Billingham, Teesside [JPG]
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
06/09/2026
June 9 2026, 23:00 (PDT) Dolby and MagentaTV Bring Fans Closer to the FIFA Worl...
04/08/2026
Dalet, a leading technology and service provider for media-rich organizations, t...
06/07/2026
Long-developed relationships and informal access, three production models, and c...
06/07/2026
The deal follows Lumine's recent acquisition of Synamedia's video-networ...
06/07/2026
This former SportsCenter producer is shaping local-team studio coverage to surro...
06/07/2026
IMS Productions and FOX Sports deployed more than 100 cameras, 32 onboard feeds,...
06/07/2026
Lumine Group Inc. has announced the completion of its acquisition of the Video Network Business from Synamedia. The business will operate as a standalone compan...
06/07/2026
NASCAR has announced a content and commercial partnership with Motorsport Network, a motorsports and automotive media platform, to distribute NASCAR original co...
06/07/2026
Versant Media Group has announced a definitive agreement to acquire Full Swing, a sports technology company, from Bruin Capital and a group of minority investor...
06/07/2026
DAZN has announced global broadcast rights to 3ICE, a professional hockey format featuring three skaters and a goalkeeper per side, with no power plays or offsi...
06/07/2026
Bundle gains 100 new synths & more
Synth Anthology 5 the largest and most feature-packed edition of UVI's hardware synth emulation bundle, bringing toge...
06/07/2026
Available now via free firmware update
MOTU have just announced that three of their popular audio interfaces now boast official Milan Certification. The 16A...
06/07/2026
Rohde & Schwarz completes Hunter Preliminary Design Review for the Integrated Co...
06/07/2026
The R&S IMAGER from Rohde & Schwarz uses millimeter wave imaging to inspect the ...
06/07/2026
The National Film and Video Foundation (NFVF), an agency of the Department of Sp...
06/07/2026
Digital Domain Appoints Industry Veteran Patrick Davenport as Executive Vice Pre...
06/07/2026
Gravity Media USA appoints Brittney Boston as Head of Business Development
Brie Clayton July 6, 2026
0 Comments
The strategic new appointment supports...
06/07/2026
Remote Editing Without Cloud Storage in Resolve
Michael Cioni July 6, 2026
0 Comments
This is a step-by-step guide that demonstrates how to setup your...
06/07/2026
Automatic Caption Translation in Adobe Premiere Pro
Colin Smith July 6, 2026
0 Comments
Here I showcase the innovative automatic caption translation f...
06/07/2026
Flavor's First Ever Managing Director Neal Cohen Retires; Longstanding Execu...
06/07/2026
How Adam Rosenwach Pivoted from Music to Medtech Without Missing a Beat What do the rehearsal room and the boardroom have in common? More than you might think...
06/07/2026
Zhongyi Optics unveils the Dreamy Zone T1 FF Cine Lens Series on Indiegogo with ...
06/07/2026
Techtel debuts insyght: making ST 2110 media discovery easy
intellisphereinsyght2026
6 July Written By Suzanne Costello
Sydney, Australia - 06 July 2026 T...
06/07/2026
Monday 6 July 2026
Sky agrees to acquire ITV Media & Entertainment, creating a ...
06/07/2026
Fresh from his World Cup heroics with Cabo Verde, Roberto Pico' Lopes will join the RT panel for Argentina v Egypt tomorrow and for the England v Norway q...
06/07/2026
Nations have long invested in domestic infrastructure to advance their economies, protect and use their data, and take advantage of technology opportunities in ...
06/07/2026
Every year, the International Conference on Machine Learning (ICML) reveals where thousands of AI researchers have decided to put their work.
This year's ...
06/07/2026
A death can be unsuspicious, but it has to be explained
What happened to Ke...
05/07/2026
We've gone to another level of integrating the graphics into the set architecture' - Zac Fields, SVP, Graphic Technology and Integration, FOX Sports...
05/07/2026
Browser-based and desktop apps available
Digital Sunset Studios have been busy working on an interesting project: a free software tool that provides compute...
04/07/2026
When Canada qualified for the FIFA World Cup 2026, OneSoccer knew this wasn'...
04/07/2026
Celebrates company's 80th anniversary
Rhodes have recently revealed that they will be producing a limited run of electric pianos in celebration of their...
04/07/2026
Blackmagic Design Cameras Empower Youth Broadcasting Program
Brie Clayton July 3, 2026
0 Comments
Blackmagic Pocket Cinema Camera 6K Pro and Blackmagi...
04/07/2026
iZotope Joins Boris FX
Boris Yamnitsky July 3, 2026
0 Comments
iZotope, the team behind RX and Ozone, is joining Boris FX. A letter from founder Boris...
04/07/2026
April 7 2026, 19:00 (PDT) Detective Conan: Fallen Angel of the Highway Opens in...
03/07/2026
New bundle & three Single Packs
Continuing to expand their already sizeable orchestral collection, VSL's latest release introduces three new Single Pack...
03/07/2026
Venue installs new ATC-equipped control room
LSO St Luke's, a unique music venue that also serves as the home of the London Symphony Orchestra, have rec...
03/07/2026
Caden Pearson appointed new Commissioning Editor for NITV
3 July, 2026
Media releases
National Indigenous Television (NITV) has strengthened its commitment...
03/07/2026
1 February 2023
SHARE Facebook Twitter Linkedin Email
Munich, Germany, 1st February 2023: Cinegy GmbH, the premier provider of software technology for digit...
03/07/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
03/07/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
03/07/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
03/07/2026
Death Star
Andy Marken July 2, 2026
0 Comments
Look, I can't get involved. I've got work to do. It's not that I like the Empire; I hate i...
03/07/2026
Berklee's New Visual Identity: Honoring Our History, Building for What's...
03/07/2026
Scripps Research scientists awarded $2M to advance global disease surveillance Two Gates Foundation grants will expand wastewater surveillance and AI-driven dis...
03/07/2026
Joan Pulupa joins Scripps Research faculty to study the organization of DNA in brain cells and its links to neurodegeneration Using smell-sensing neurons and ad...
02/07/2026
Entering her senior year, this hometown girl is paving a career in live sports production gaining experience in replay and audio and as a TD
In the live-sports...
02/07/2026
In-venue and creative video staffers at the professional and collegiate level ha...
FUJIFILM Diosynth Biotechnologies confirms £400 million investment plans to create the largest multi-modal biopharmaceutical manufacturing site in the United Kingdom The expansion is expected to create up to 350 highly-skilled jobs on Teesside. 
